153 results for “Nifty support”
Last week was defined by a significant market correction, driven by relentless
Every market cycle feels different when you're living through it, until
Sudeep Pharma Limited is a technology-led specialty ingredients manufacturer serving the
Indian markets may open cautiously today, as global signals appear mixed. GIFT
Our morning brief anticipated consolidation vs. breakout around 25,100-25,500
The expectation of increased foreign inflows, however, did not immediately materialize in
TCS delivered operationally sound execution with margin expansion despite wage hikes, but
The market began the session on a note of cautious optimism, with
Tax rationalization involves simplifying and optimizing tax structures to improve compliance and
Global weakness weighs on Indian markets as GIFT Nifty signals a
Focus shifts to Reliance Industries' Q2 results announcement and over 80 companies
Indian pharma experiencing bifurcation - diversified players (Lupin, Cipla) thriving; single-product-dependent
Indian agro sector experiencing bifurcation - Large players (PI, UPL) with diversified portfolios
In this morning’s newsletter, we highlighted India’s economic boom supported
Morning brief highlighted GST 2.0 tailwinds for Autos/FMCG and possible IT underperformance
Indian markets gear up for September with GIFT Nifty indicating a
Mankind Pharma is India’s 4th largest pharmaceutical company by domestic market
Foreign institutional investors turned net buyers after recent selling, purchasing ₹161.84 crore
